Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
InterShunt
AddedFeb 15, 2024
UpdatedJun 18, 2026
InterShunt

InterShunt

Series A

InterShunt: Providing catheter-based, minimally-invasive heart relief procedures without implants since 2015.

HQ
Plymouth, MN, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded in 2015 and headquartered in St. Louis, Missouri, InterShunt focuses on developing catheter-based, minimally-invasive procedures to alleviate symptoms for millions suffering from heart failure. The company’s core mission is to provide effective heart failure relief through left atrial decompression without the need for implants. InterShunt aims to revolutionize heart failure treatment with its innovative, simple catheter procedure, targeting a significant unmet medical need in the cardiovascular market.

InterShunt has attracted notable scientific advisors and board members who are experts in cardiology and medical device innovation. The company has achieved significant milestones in clinical trials, demonstrating the efficacy and safety of its procedures. By offering a non-implant solution, InterShunt has the potential to significantly impact patient outcomes and reduce healthcare costs, positioning itself as a leader in the minimally-invasive heart failure treatment space.

InterShunt - Similar Companies

EndoShunt Medical logo

EndoShunt Medical

endoshunt.com

InterValve logo

InterValve

Laplace Interventional logo

Laplace Interventional

laplaceint.com

Capstan Medical logo

Capstan Medical

capstanmedical.com

Reprieve Cardiovascular logo

Reprieve Cardiovascular

reprievecardio.com

Micro Interventional Devices logo

Micro Interventional Devices

Second Heart Assist logo

Second Heart Assist

secondheartinc.com

InterCure logo

InterCure

intercure.com

MitraSpan logo

MitraSpan

Corinnova logo

Corinnova

corinnova.com

ReliantHeart logo

ReliantHeart

reliantheart.com

Corveus Medical logo

Corveus Medical

corveusmedical.com

Cardiac Dimensions logo

Cardiac Dimensions

Phoenix Cardiac logo

Phoenix Cardiac

Procyrion logo

Procyrion

InterShunt - Quick Facts

Who are InterShunt's competitors?

Companies similar to InterShunt include EndoShunt Medical, InterValve, Laplace Interventional and Capstan Medical.

When was InterShunt founded?

InterShunt was founded in 2015.

Where is InterShunt's headquarters located?

InterShunt's headquarters is located in Plymouth, MN, US.

How much has InterShunt raised to-date?

As of Jun 6, 2023, InterShunt has raised a total of $8M (USD).

How many employees does InterShunt have?

InterShunt has 6 employees as of Feb 5, 2024.

InterShunt - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified